Yesterday, the U.S. Supreme Court voted 7-2 to extend an administrative block on a preliminary lower court ruling and keep mail-order access to the chemical abortion drug Mifepristone available while litigation continues. Thursday’s extension of the stay allows the drug to be sent through the mail while the Fifth Circuit appeal proceeds toward a permanent ruling.
On May 8, a three-judge panel from the U.S. Fifth Circuit Court of Appeals preliminarily ruled that the U.S. Food and Drug Administration (FDA) must reinstate the in-person requirement for dispensing Mifepristone. The Fifth Circuit’s decision temporarily blocked the 2023 FDA rule change that allowed Mifepristone to be distributed through the mail without an in-person medical visit. The three-judge panel ruled unanimously that the state of Louisiana was likely to prevail on the merits in its challenge to the pill’s 2023 deregulation adopted by Biden’s administration, and the Fifth Circuit will now proceed toward a permanent decision by fully examining those merits.
Read Full Article: https://www.lifenews.com/2026/05/15/justice-clarence-thomas-confirms-comstock-act-bans-mail-order-abortions/
